Possible future applications of optogenetics in MS therapy include the induction of oligodendrocyte proliferation, myelin synthesis, enhancing the repair of demyelinating processes, and modulating the severity of MS symptoms.
Multiple sclerosis clinicians in Australia report that guideline application can improve standards of care but report varying practices in applying treatment guidelines.
Youth-centered approaches are needed to support self-management-related concerns for youth with multiple sclerosis during the transition to adult care.
Health care professionals can support participation in running for individuals with multiple sclerosis by providing strategies for the safe adaptation of exercise and for ways to manage symptoms before and during exercise.